1. Home
  2. INLX vs XLO Comparison

INLX vs XLO Comparison

Compare INLX & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

HOLD

Current Price

$7.65

Market Cap

35.9M

Sector

Technology

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.54

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLX
XLO
Founded
1996
2016
Country
United States
United States
Employees
N/A
73
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.9M
39.4M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
INLX
XLO
Price
$7.65
$0.54
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
1.4K
452.8K
Earning Date
01-01-0001
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.79
EPS
N/A
N/A
Revenue
$11,336.00
$6,344,000.00
Revenue This Year
N/A
$626.78
Revenue Next Year
$15.82
$79.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.50
$0.50
52 Week High
$15.72
$1.18

Technical Indicators

Market Signals
Indicator
INLX
XLO
Relative Strength Index (RSI) 39.31 37.87
Support Level $7.50 $0.50
Resistance Level $8.29 $0.74
Average True Range (ATR) 0.12 0.04
MACD -0.04 0.00
Stochastic Oscillator 0.00 32.98

Price Performance

Historical Comparison
INLX
XLO

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: